السوق العالمية لعلاج الوذمة الوعائية المكتسبة - اتجاهات الصناعة والتوقعات حتى عام 2028

تحليل السوق والرؤى : سوق علاج الوذمة الوعائية المكتسبة العالمي

من المتوقع أن يحقق سوق علاج الوذمة الوعائية المكتسبة نموًا في السوق في الفترة المتوقعة 2021-2028. تحلل شركة Data Bridge Market Research السوق لتتوقع نموًا بمعدل نمو سنوي مركب قدره 4.80% في الفترة المتوقعة المذكورة أعلاه.

الوذمة الوعائية المكتسبة هي اضطراب نادر يتميز بالوذمة. تحدث على شكل وذمة تحت الجلد مؤقتة ومتكررة وتنتج عن نقص مثبط C1 المكتسب (C1-INH). كما تؤدي إلى تورم الوجه والأطراف والشفتين واللسان أو الأعضاء التناسلية وتسبب أيضًا ألمًا في البطن. يمكن أن تكون هذه الحالة مناعية أو غير مناعية وغالبًا ما تكون ناجمة عن الحساسية. تظهر أيضًا مع الشرى وأعراض الحساسية الأخرى. ترتبط بانتظام بأمراض التكاثر اللمفي والأورام الخبيثة في الخلايا البائية. 

إن ارتفاع معدل انتشار الوذمة الوعائية المكتسبة، وتزايد الإنفاق على الرعاية الصحية، وارتفاع عدد السكان المسنين، والزيادة في الطلب على العلاج المتقدم للوذمة الوعائية المكتسبة، وتزايد التمويل الحكومي والمبادرات المتزايدة من قبل الحكومة والمنظمات الخاصة لنشر الوعي حول علاج الأمراض النادرة هي العوامل التي من شأنها توسيع سوق علاج الوذمة الوعائية المكتسبة.

إن الارتفاع في أنشطة البحث والتطوير والتقدم في خيارات العلاج من شأنه أن يوفر فرصًا مفيدة لسوق علاج الوذمة الوعائية المكتسبة في الفترة المتوقعة 2021-2028.

• من ناحية أخرى، فإن التكلفة العالية للعلاج والآثار الجانبية المرتبطة بالأدوية هي العوامل التي ستعيق نمو السوق. إن الافتقار إلى الوعي بالأمراض النادرة وعلاجها سيشكل تحديًا لسوق علاج الوذمة الوعائية المكتسبة في فترة التنبؤ المذكورة أعلاه.

This acquired angioedema treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the acquired angioedema treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Acquired Angioedema Treatment Market Scope and Market Size

The acquired angioedema treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the acquired angioedema treatment market is segmented into type 1 and type 2.
• On the basis of treatment, the acquired angioedema treatment market is segmented into icatibant, ecallantide, corticosteroids, antihistamines, fresh frozen plasma (FFP) and others.
• On the basis of diagnosis, the acquired angioedema treatment market is segmented into testing C1-INH and C4, MRI, CT scan, autoantibody test, laboratory tests and others.
• On the basis of dosage, the acquired angioedema treatment market is segmented into tablet, injection, solution and others.
• On the basis of route of administration, the acquired angioedema treatment market is segmented into oral, subcutaneous, intramuscular and others.
• On the basis of end-users, the acquired angioedema treatment market is segmented into clinic, hospital and others.

The acquired angioedema treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Acquired Angioedema Treatment Market Country Level Analysis

Acquired angioedema treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the acquired angioedema treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the acquired angioedema treatment market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Acquired angioedema treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Acquired Angioedema Treatment Market Share Analysis

Acquired angioedema treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acquired angioedema treatment market research.

اللاعبون الرئيسيون الذين تم تغطيتهم في تقرير سوق علاج الوذمة الوعائية المكتسبة هم Mylan NV و Teva Pharmaceutical Industries Ltd. و Sanofi و Novartis AG و Cipla Inc. و AstraZeneca و GlaxoSmithKline plc و Merck Sharp & Dohme Corp. و Takeda Pharmaceutical Company Limited و Fresenius Kabi AG و CSL و Pharming Group NV و BIOCRYST PHARMACEUTICALS, INC. و Attune Pharmaceuticals و Ionis Pharmaceuticals و Adverum Biotechnologies, Inc. و Johnson & Johnson Private Limited و Baxter و Bayer AG و Merck KGaA و Sun Pharmaceutical Industries Ltd. و Sumitomo Corporation، من بين اللاعبين المحليين والعالميين الآخرين. تتوفر بيانات حصة السوق للعالم وأمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ (APAC) والشرق الأوسط وأفريقيا (MEA) وأمريكا الجنوبية بشكل منفصل. يفهم محللو DBMR نقاط القوة التنافسية ويوفرون تحليلاً تنافسيًا لكل منافس على حدة.

SKU-66639